Resources

The life sciences sector in the UK has been the subject of significant attention over recent years. Activity in the sector has been spurred on by a multitude of drivers and its potential has also been frequently highlighted by the UK government.

In this blog, Olivia Fletcher-Hogg, Programme Manager at Pioneer Group, provides actionable insights for building high-performance teams in the life sciences and biotech sector, from fostering a positive work culture to empowering employee development.

We are very keen to hear from the UK Life Science occupier community. By understanding what life sciences occupiers want and need, we/ Cushman & Wakefield can help to identify/ secure the right space at the right price point.

Explore the groundbreaking developments in the UK's life sciences sector with Gino Martini, CEO of Precision Health Technologies Accelerator (PHTA) at Birmingham Health Innovation Campus. In this blog, Gino highlights Birmingham's role in addressing the critical need for laboratory and research spaces, positioning the West Midlands as a global hub for innovation and economic growth.

ICBA Geneva delegation special, party conferences in full swing, BIA fringe event at the Conservative conference, Evotec opening, and Regulatory conference all set for Thursday.

In this blog, MedCity CEO Neelam Patel expresses her pride in London's growth as a beacon for life sciences. Now stepping down from her role after nine years in the organisation’s leadership, Neelam takes this opportunity to share her reflections on London’s evolution as a life sciences supercluster, powered by innovation districts spread across the city.

ValiRx PLC, a life science company focused on early-stage cancer therapeutics and women's health, has announced three senior appointments to its newly incorporated subsidiary company, Inaphaea BioLabs (Inaphaea).

ValiRx PLC, a life science company focused on early-stage cancer therapeutics and women's health, has taken the lease on laboratory and office facilities at MediCity Nottingham as it embarks on the next stage of its strategy to launch a translational Contract Research Organisation (tCRO).